Chronic stress may be associated with an increased chance of stroke in some younger adults - particularly women.

Some people living with chronic stress have a higher risk of stroke, according to a new study. The study looked at younger adults and found an association between stress and stroke, with no known ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...

The research team tracked the health of 426 people between 18 to 49, including those who had ischemic stroke with no known ...

Some people living with chronic stress have a higher risk of stroke, according to a study published on March 5, 2025, online in Neurology, the medical journal of the American Academy of Neurology.

Chronic stress could be a hidden stroke risk for younger women, according to new research. Scientists found that women aged 18 to 49 who reported moderate stress levels had a significantly higher ...

Every year, millions of people die from stroke. In order to win against this disease which occurs the moment when a blood ...

A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...

Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or ...

Tenecteplase is administered as a single, 5-second intravenous bolus, providing a faster and simpler option compared to the standard 60-minute infusion of alteplase.

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...